Ropes & Gray advised TPG in the sale of Immucor, Inc. to Werfen for approximately $2 billion, with closing subject to customary regulatory approvals. The announcement was made public on Nov. 3 in a press release.
TPG is a global alternative asset management firm with $127 billion of assets under management and investment and operational teams in 12 offices globally. Immucor, headquartered in Norcross, Georgia, has a global presence in transfusion and transplant in vitro diagnostics.
The Ropes & Gray team was led by private equity partners Michael Roh and James C. Davis, and included tax partner Adam Greenwood, benefits partner Matt Jones, litigation & enforcement partner Ruchit Patel and private equity associate Rebecca Yang.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.